Research Site — New York, New York

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

424

Registered studies

165

Active

Recruiting now

203

Completed

Stopped or withdrawn

Most-studied conditions

Diffuse Large B-Cell Lymphoma · Relapsed/Refractory Follicular Lymphoma · Ulcerative Colitis Chronic · Heart Failure With Reduced Ejection Fraction

Recently updated registry entries

NCT07554339 — A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… (Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)
NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.